TIAA CREF Investment Management LLC raised its stake in Medidata Solutions, Inc. (NASDAQ:MDSO) by 2.6% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 153,565 shares of the company’s stock after buying an additional 3,925 shares during the quarter. TIAA CREF Investment Management LLC owned 0.27% of Medidata Solutions worth $12,009,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the business. Clearbridge Investments LLC lifted its position in Medidata Solutions by 61.4% in the 1st quarter. Clearbridge Investments LLC now owns 2,449,038 shares of the company’s stock worth $141,285,000 after buying an additional 931,729 shares in the last quarter. Renaissance Technologies LLC boosted its stake in shares of Medidata Solutions by 562.8% during the 1st quarter. Renaissance Technologies LLC now owns 396,992 shares of the company’s stock valued at $22,902,000 after buying an additional 337,098 shares during the period. Teachers Advisors LLC boosted its stake in shares of Medidata Solutions by 254.0% during the 1st quarter. Teachers Advisors LLC now owns 371,554 shares of the company’s stock valued at $21,435,000 after buying an additional 266,606 shares during the period. Vanguard Group Inc. boosted its stake in shares of Medidata Solutions by 5.1% during the 1st quarter. Vanguard Group Inc. now owns 4,874,974 shares of the company’s stock valued at $281,237,000 after buying an additional 235,190 shares during the period. Finally, State Street Corp boosted its stake in shares of Medidata Solutions by 17.1% during the 1st quarter. State Street Corp now owns 1,432,120 shares of the company’s stock valued at $82,615,000 after buying an additional 209,074 shares during the period. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Medidata Solutions, Inc. (MDSO) opened at 79.94 on Wednesday. The firm has a market capitalization of $4.53 billion, a P/E ratio of 129.14 and a beta of 1.77. Medidata Solutions, Inc. has a 52-week low of $46.10 and a 52-week high of $85.92. The firm’s 50-day moving average is $74.94 and its 200 day moving average is $71.83.

Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings results on Tuesday, July 18th. The company reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.03. Medidata Solutions had a net margin of 7.07% and a return on equity of 11.14%. The company had revenue of $137.41 million during the quarter, compared to analysts’ expectations of $134.28 million. During the same period last year, the business earned $0.24 EPS. The business’s quarterly revenue was up 19.9% on a year-over-year basis. Equities analysts anticipate that Medidata Solutions, Inc. will post $1.29 EPS for the current year.

Several equities analysts have recently commented on the stock. Zacks Investment Research upgraded shares of Medidata Solutions from a “sell” rating to a “hold” rating in a report on Wednesday, September 20th. Royal Bank Of Canada initiated coverage on Medidata Solutions in a report on Tuesday, September 19th. They set a “sector perform” rating and a $82.00 price objective for the company. KeyCorp reiterated a “buy” rating and set a $86.00 price objective on shares of Medidata Solutions in a report on Sunday, September 17th. Jefferies Group LLC reissued a “hold” rating and set a $78.00 price objective on shares of Medidata Solutions in a research report on Tuesday, August 22nd. Finally, BidaskClub cut Medidata Solutions from a “buy” rating to a “hold” rating in a research report on Monday, July 24th. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Medidata Solutions presently has an average rating of “Buy” and a consensus price target of $83.83.

In related news, COO Michael L. Capone sold 5,000 shares of the stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $74.53, for a total transaction of $372,650.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 5.80% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another domain, it was stolen and republished in violation of US and international trademark & copyright law. The original version of this news story can be accessed at https://www.watchlistnews.com/tiaa-cref-investment-management-llc-grows-holdings-in-medidata-solutions-inc-mdso/1606891.html.

Medidata Solutions Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions, Inc. (NASDAQ:MDSO).

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.